Vioxx Safety Issues Illustrate Need For Placebo-Controlled Trials – Editorial
This article was originally published in The Pink Sheet Daily
Vioxx safety problems illustrate importance of placebo-controlled trials, former FDA reviewer argues in PLoS Medicine. However, German researchers assert that placebo-controlled trials are unethical if there is sufficient evidence that an effective therapy exists.
You may also be interested in...
The Solicitor General says the Supreme Court should not hear the Commission's appeal of a case brought against Schering-Plough regarding a generic drug settlement.
Fox Chase Cancer Center’s Weeks concurs that umbrella agreements with pharma and biotech companies are becoming more common.
Tests are currently available to identify patient responders, but clinicians need guidance on how to adjust dosing for them, the HHS Secretary's Advisory Committee on Genetics, Health & Society agreed.